Seroatlas · Human Serome Atlas

IRF2BP2

Interferon regulatory factor 2-binding protein 2

Also known as: I2BP2_HUMAN, IRF-2BP2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q7Z5L9
Gene
IRF2BP2
Ensembl
ENSG00000168264
Chromosome
1
Canonical length
587 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

587 residues, UniProt reviewed canonical sequence.

>Q7Z5L9|IRF2BP2
     1  MAAAVAVAAA SRRQSCYLCD LPRMPWAMIW DFTEPVCRGC VNYEGADRVE FVIETARQLK
    61  RAHGCFPEGR SPPGAAASAA AKPPPLSAKD ILLQQQQQLG HGGPEAAPRA PQALERYPLA
   121  AAAERPPRLG SDFGSSRPAA SLAQPPTPQP PPVNGILVPN GFSKLEEPPE LNRQSPNPRR
   181  GHAVPPTLVP LMNGSATPLP TALGLGGRAA ASLAAVSGTA AASLGSAQPT DLGAHKRPAS
   241  VSSSAAVEHE QREAAAKEKQ PPPPAHRGPA DSLSTAAGAA ELSAEGAGKS RGSGEQDWVN
   301  RPKTVRDTLL ALHQHGHSGP FESKFKKEPA LTAGRLLGFE ANGANGSKAV ARTARKRKPS
   361  PEPEGEVGPP KINGEAQPWL STSTEGLKIP MTPTSSFVSP PPPTASPHSN RTTPPEAAQN
   421  GQSPMAALIL VADNAGGSHA SKDANQVHST TRRNSNSPPS PSSMNQRRLG PREVGGQGAG
   481  NTGGLEPVHP ASLPDSSLAT SAPLCCTLCH ERLEDTHFVQ CPSVPSHKFC FPCSRQSIKQ
   541  QGASGEVYCP SGEKCPLVGS NVPWAFMQGE IATILAGDVK VKKERDS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IRF2BP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.64
Highest tissue expression
148 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 148 nTPM
  • blood vessel: 69 nTPM
  • skin: 60 nTPM
  • thyroid gland: 54 nTPM
  • endometrium: 52 nTPM
  • salivary gland: 52 nTPM

Single-cell type

  • epididymal basal cells: 353 nCPM
  • gastric progenitor cells: 308 nCPM
  • suprabasal keratinocytes: 307 nCPM
  • endometrial glandular cells: 305 nCPM
  • neutrophil progenitors: 284 nCPM
  • basal keratinocytes: 282 nCPM

Immune cell

  • plasmacytoid DC: 18 nTPM
  • basophil: 10 nTPM
  • eosinophil: 8.5 nTPM
  • naive CD4 T-cell: 4.9 nTPM
  • memory CD4 T-cell: 4.8 nTPM
  • myeloid DC: 4.7 nTPM

Brain region

  • white matter: 92 nTPM
  • medulla oblongata: 85 nTPM
  • pons: 77 nTPM
  • basal ganglia: 73 nTPM
  • midbrain: 73 nTPM
  • spinal cord: 72 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IRF2BP2.

Disease | AllUniProt

Conditions IRF2BP2 is implicated in, by any mechanism.

Disease | GeneticClinVar

4 pathogenic / likely-pathogenic of 810 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.45
gnomAD pLI
0.85
gnomAD missense Z
0.62
DepMap mean gene effect
-0.11
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IRF2BP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IRF2BP2 as an antibody target. Whether an autoantibody or antibody against IRF2BP2 could matter depends on whether native IRF2BP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IRF2BP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IRF2BP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IRF2BP2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...